Search

Search Constraints

You searched for: Author/Creator Dong, Baijun

Search Results

2. Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer. (19th February 2017)

4. Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first‐line therapy for Chinese patients with metastatic renal cell carcinoma. Issue 1 (8th August 2017)

5. Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination. Issue 3 (27th September 2021)

9. HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1. Issue 12 (6th March 2021)